For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

Growing up in a society with a wide gap between the rich and the poor is linked to higher rates of depressive symptoms later ...

Introduction Depression is a major global health challenge, with onset commonly occurring in youth. There is an urgent need to better understand the epidemiology of depression to facilitate better ...

Objectives Depressive symptoms are highly prevalent among medical students globally, yet estimates from Pakistan remain fragmented and inconsistent across studies. Medical students in Pakistan face ...

A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an ...

SAN ANTONIO, May 27, 2026 /PRNewswire/ -- A peer-reviewed case study published in the journal Transcranial Magnetic Stimulation reports that an accelerated transcranial magnetic stimulation (aTMS) ...

A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found. The study, published in the journal ...

Explore how two corporate leaders navigated burnout and the hidden cost of organizational pressure reveal why well-being is essential to leadership conviction.

Case studies serve as an excellent resource for devising innovative sales strategies, and providing insights into successful maneuvers and problem-solving techniques. Innovation Inspired by Proven ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

A single dose of psychedelics significantly reduced symptoms in people with major depressive disorder, a new study found. The clinical trial was led by researchers at Imperial College London, where ...

COMP360 shows rapid symptom improvement in depression study COMP360 may compete with J&J's Spravato if approved Compass plans FDA meeting for rolling submission Feb 17 (Reuters) - Compass Pathways ...